Kalvista Pharma (NASDAQ: KALV) reported first quarter EPS of $-0.74, $0.14 better than the analyst estimate of $-0.88. Revenue for the quarter came in at $0.00 versus the consensus estimate of $0.
Kalvista Pharma’s stock price closed at $10.77. It is up 8.68% in the last 3 months and down -32.77% in the last 12 months.
Kalvista Pharma saw 1 positive EPS revisions and 1 negative EPS revisions in the last 90 days. See Kalvista Pharma’s stock price’s past reactions to earnings here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar.